Thalia Therapeutics

Chellaston, United Kingdom

Thalia Therapeutics is a drug reformulation company.

$3.6M raised

Jun 2026

Post-IPO Secondary

Biotechnology Genetics Nanotechnology Oncology Pharmaceutical

Top Investors

Innovate UK

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Thalia Therapeutics

How much funding has Thalia Therapeutics raised?

Thalia Therapeutics has raised $3.6M in total funding. The most recent round was Post-IPO Secondary. The last funding was announced in June 2026.

Who are Thalia Therapeutics's investors?

Thalia Therapeutics's investors include Innovate UK.

Where is Thalia Therapeutics headquartered?

Thalia Therapeutics is headquartered in Chellaston, United Kingdom.

What does Thalia Therapeutics do?

Thalia Therapeutics is a drug reformulation company.

What stage is Thalia Therapeutics at?

Thalia Therapeutics is at the Post-IPO Secondary stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 24, 2026.

MLA

"Thalia Therapeutics — Funding & Investors." VCBacked, June 24, 2026, https://www.vcbacked.co/company/thalia-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2026). Thalia Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/thalia-therapeutics

Wikipedia (cite web)

{{cite web |title=Thalia Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/thalia-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 24, 2026.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K